Publication | Closed Access
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
425
Citations
20
References
2016
Year
Hematological MalignancyTranslational MedicineAcute LeukaemiaMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyClinical TrialsImmunologyPharmacologyMyeloid NeoplasiaPharmacotherapyOncologyPhase 1Bromodomain Inhibitor Otx015Cancer ResearchHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1